Jane Street »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Jane Street

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Jane Street

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.6M 3.8M 0.94

More positions owned by Jane Street

Spdr S&p 500 Etf Tr option Put Option
Spdr S&p 500 Etf Tr option Call Option
Powershares Qqq Etf Put Opt 01/19 154.0 put Put Option
Tesla Motors Inc cmn Call Option
Tesla Motors Inc cmn Put Option
Ishares Tr Index option Put Option
Powershares Qqq Trust Call Option
Nvidia Corp option Put Option
Amazon Com Inc option Put Option
Nvidia Corp option Call Option
Apple Inc option Call Option
Apple Inc option Put Option
Facebook Inc call Call Option
Ishares Tr option Call Option
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Jane Street

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
Leucadia National Corporation
SSI Investment Management
CSS
Readystate Asset Management

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1